Health Products

Apo-Loperamide

· Published by Health Canada · Official notice

Details

Alert type: Recall
Category: Drugs
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCommon nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
(All batches packaged in blisters) REX 6x4 REX 6x2 REX 6x1 HT4497 HT4489 HW5312 HW5307 HW5310 HX9509 HX9502 HX9507 JA8314 JA8322 JA8317 JE2164 JE2162 JE2163 JF3957 JF3954 JF3955 VDM 6x4 PDM 6x1 PHA 6 HR1177 JA8337 HR1236 HW5314 JD7474 HW5400 JA8336 HX9515 JE2160 JC5346 JF3950 SOB 6x2 SOB 6x4 APC 10x6 APC 6x24 HW5306 HR1178 HW8104 HW8105 HX9513 HW5305 JC6150 JX9521 JA8330 HX9514 JD7484 JA8446 JD7476 JA8335 JE5909 JF3958 JD7475 REM 12 REM 24 HZ7062 HZ7061Apo-Loperamide
Recalling Firm
Apotex Inc 150 Signet Drive Toronto, Ontario M9L 1T9
Marketing Authorization Holder
Apotex Inc 150 Signet Drive Toronto, Ontario M9L 1T9
TabletsDIN 022120052 mg

Reason

Routine stability monitoring detected OOS levels of a RC (oxidation product of loperamide that can increase significantly with exposure to air and high humidity). All batches that have been packaged in blisters are impacted.

Depth of distribution

Apotex labelled product: Canada, Libya (JC6150, JA8446)
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime